Castik Capital and Abry Partners acquire Reward Gateway
Great Hill Partners has sold Reward Gateway to Castik Capital Partners GmbH and Abry Partners.
Castik Capital is a German-based private equity firm. Founded in 2014, it focuses on identifying and developing investment opportunities across Europe. Since its founding in 1989, Abry has focused on media, communications, business and information services to become one of the most experienced private equity firms investing in North America and Europe.
Reward Gateway helps more than 1,700 of the world’s leading companies to attract, engage and retain their best people with an employee engagement platform that brings employee benefits, discounts and perks, reward and recognition, employee wellbeing and communications into one unified hub.
Great Hill Partners is a private equity firm with US$2.7 billion under management.
Oaklins Cavendish, based in the UK, advised Castik Capital on the acquisition of Reward Gateway.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreApollo Executive Search has entered into a strategic partnership with Schelstraete Delacourt
Apollo Executive Search, a Netherlands-based firm specializing in executive search services for mid-market private equity portfolio companies and technology scale-ups, has formed a strategic partnership with Schelstraete Delacourt, a leading executive search, board search and executive assessment firm in the Benelux.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more